HEALTH

Reckitt Benckiser has launched a liquid formulation of its popular Mucinex brand to help fight coughs and colds in the coming season called Maximum Strength Mucinex Fast-Max Liquids. The four new formulations combine the mucus-busting power of Mucinex with maximum-strength medicines for multisymptom relief. Two of the formulations contain acetaminophen to relieve fever and pain, three contain dextromethorphan as a cough suppressant and three contain the antihistamine phenylephrine. Maximum Strength Mucinex Fast-Max Liquid products are indicated for ages 12 years and older.

SALT LAKE CITY — Schiff Nutrition on Wednesday expanded its supply agreement with Aker BioMarine through June 2016 for high-quality krill oil.

Schiff is granted certain exclusive sales rights and the parties have agreed to collaborate on future innovations.

PARAMUS, N.J. — Inergetics on Tuesday announced that, effective in September, it will become the exclusive provider of all nutritional products for NCAA athletes at the U.S. Military Academy at West Point, N.Y.

BOSTON — People with lower percentages of body fat are not necessarily at lower risk for diabetes and heart disease, according to a new international study.

The study identified a gene that is linked with having less body fat but also with having an increased risk of Type 2 diabetes and heart disease. The investigators examined the genomes of more than 75,000 people and found that the gene, IRS1, was linked to less body fat, but also to unhealthy levels of cholesterol and blood glucose.

NEW YORK — Discovery Communications recently announced the launch of a line of branded Discovery Fit & Health consumer products designed to provide proactive health and fitness lifestyle solutions for health-conscious consumers.

SAN DIEGO — Patients with Type 1 diabetes using an insulin product made by MannKind expressed a better opinion about insulin therapy than those taking the standard treatment, according to a study presented at the American Diabetes Association’s 71st Scientific Sessions.

MannKind said that patients taking the investigational inhaled insulin Afrezza (insulin human [rDNA origin]) with basal insulin came to view insulin therapy more positively during the 16-week study than those taking Eli Lilly’s injected Humalog (insulin lispro [rDNA origin]) with basal insulin.

SAN DIEGO — A once-monthly formulation of a drug made by Amylin Pharmaceuticals, Eli Lilly and Alkermes improved glucose control in patients with Type 2 diabetes, according to results of a mid-stage clinical trial presented at the American Diabetes Association’s 71st Scientific Sessions.

The three companies said once-monthly injections of the drug exenatide improved blood-sugar control and produced modest weight loss in the 121-patient phase-2 study.

FRESNO, Calif. — Consuming nuts in place of carbohydrates may help improve long-term blood-sugar control and lower cholesterol levels among Type 2 diabetics, according to a new study.